10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort A: 6 patients were treated with azer-cel and lymphodepletion (chemotherapy) 1 ...
Wall Street just leveled a stark warning against investing in Canadian cannabis stocks and said investors should shift their attention to emerging US names, instead. In a Monday morning note, Cowen ...
Hosted on MSN
Imugene announces Phase Ib azer-cel efficacy data
Imugene has announced further positive efficacy data from its ongoing Phase Ib azer-cel (azercabtagene zapreleucel) trial in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients. The ...
Since the February update, an additional 5 patients have been dosed, resulting in 2 Complete Responses (CR) and 3 Partial Responses (PR) 75% Overall Response rate (ORR): 6 total CR and 3 PR in Phase ...
Imugene Limited, a clinical-stage immuno-oncology company, has announced exciting new data from its phase 1b clinical trial evaluating azer-cel (azercabtagene zapreleucel) in patients with ...
Today has been busy with ransomware and we have some some good news coming later today. For this story, though, we are going to take a look at the Azer variant of the Cryptomix ransomware. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results